top of page
Latest Articles and Analysis
Search
Jen's Half Cents: Fixing the Broken Patient Advocacy Pipeline
Broken advocacy pipeline lacks investment in leadership development, compensation, and mentorship.

Jen Laws
May 23, 20215 min read
Novel Developments: Merck & Gilead Partner on New ARVs
Merck-Gilead partnership on long-acting injectables Islatravir and Lenacapavir for HIV treatment.

Jen Laws
Mar 28, 20213 min read
Advocacy in 2021…and Beyond
CANN outlines advocacy priorities for the Biden era, from 340B reform and drug pricing to HIV criminalization and health equity.
Community Access National Network
Dec 11, 20204 min read
We Need Your Support Today!
bottom of page